Prevention of amlodipine absorption by activated charcoal: Effect of delay in charcoal administration

British Journal of Clinical Pharmacology

Volumn 43, Issue 1, 1997, Pages 29-33

  Laine, Kari ^a   Kivistö, Kari T ^b   Laakso, Into ^b   Neuvonen, Pertti J ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Absorption; Amlodipine; Charcoal; Poisoning

Indexed keywords

ACTIVATED CARBON; AMLODIPINE; AMLODIPINE BESYLATE; CHARCOAL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EXCRETION; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031038416     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1997.tb00029.x     Document Type: Article

References (21)

1. Meredith PA, Elliot HL. Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet 1992; 22: 22-31.
2. Abernethy AR. Pharmacokinetics and pharmacodynamics of amlodipine. Cardiology 1992; 80: 31-36.
3. Faulkner JK, McGibney D, Chasseaud LF, Perry JL, Taylor IW. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after repeated oral doses given once daily. BrJ Clin Pharmacol 1986; 22: 21-25.
4. Litovitz T, Schmitz BF, Holm MA. Annual report of the American Association of Poison Control Centres national data collection system. Am J Emerg Med 1988; 7: 495-545.
5. Ramoska EA, Spiller HA, Winter M, Borys D. A one-year evaluation of calcium channel blocker overdoses: Toxicity and treatment. Ann Emerg Med 1993; 22: 196-200.
6. Neuvonen PJ, Olkkola KT. Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses. Med Toxicol 1988; 3: 33-58.
7. Neuvonen PJ, Elfving SM, Elonen E. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man. Eur J Clin Pharmacol 1978; 13: 213-218.
8. Neuvonen PJ, Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. Eur J Clin Pharmacol 1980; 17: 51-57.
9. Olkkola KT, Neuvonen PJ. Do gastric contents modify antidotal efficacy of oral activated charcoal? Br J Clin Pharmacol 1984; 18: 663-669.
10. Kirschenbaum LA, Mathews SC, Sitar DS, Tenenbein M. Whole-bowel irrigation versus activated charcoal in sorbitol for the ingestion of modified-release pharmaceuticals. Clin Pharmacol Ther 1989; 46: 264-271.
11. Lim DT, Singh P, Nourtis S, Dela-Cruz RD. Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal. Ann Emerg Med 1986; 15: 1303-1307.
12. Ferner RE, Odemuyiwa O, Field AB, Walker S, Volans GN, Bateman DN. Pharmacokinetics and toxic effects of diltiazem in massive overdose. Hum Toxicol 1989; 8: 497-499.
13. Buckley NA, Dawson AH, Howarth DM, Whyte IM. Slow release verapamil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium. Med J Aust 1993; 158: 202-204.
14. Goldberg MJ, Spector R, Park GD, Johnson GF, Roberts P. The effect of sorbitol and activated charcoal on serum theophylline concentrations after slow-release theophylline. Clin Pharmacol Ther 1987; 41: 108-111.
15. Minton NA, Henry JA. Prevention of drug absorption in simulated theophylline overdose. Clin Toxicol 1995; 33: 43-49.
16. Neuvonen PJ, Vartiainen M, Tokola O. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption. Eur J Clin Phamacol 1983; 24: 557-562.
17. Curtis RA, Barone J, Giacona N. Efficacy of ipecac and activated charcoal/cathartic in prevention of salicylate absorption in a simulated overdose. Arch Int Med 1984; 144: 48-52.
18. Neuvonen PJ, Olkkola KT. Activated charcoal and syrup of ipecac in prevention of cimetidine and pindolol absorption in man after administration of metoclopramide as an antiemetic agent. Clin Toxicol 1984; 22: 103-114.
19. Kulig K, Bar-Or D, Cantrill SV, Rosen P, Rumack BH. Management of acutely poisoned patient without gastric emptying. Ann Emerg Med 1985; 14: 562-567.
20. Pond SM, Lewis-Driver DJ, Williams GM, Green AC, Stevenson NW. Gastric emptying in acute overdose: a prospective randomised controlled trial. Med J Aust 1995; 163: 345-349.
21. Saetta JP, March S, Gaunt ME, Quinton DN. Gastric emptying procedures in the self-poisoned patient: are we forcing gastric content beyond the pylorus? J Roy Soc Med 1991; 84: 274-276.